This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe   Archive    Media Kit Sep. 12, 2013

Home   About ITNS   Members Only   Membership   Education   Store   Careers   Research   Support   Contact Us  



Prevent Hazardous Drug Exposure

PhaSeal has been the only clinically proven closed-system drug transfer device for the safe handling of hazardous drugs.

 



See you at the Symposium!
ITNS
The 22nd Annual ITNS Symposium is the premier event in transplant nursing. We're looking forward to three exciting days of learning and networking. Be sure to print your handouts to bring with you to the meeting. An email with instructions for accessing the handouts will be sent to everyone registered for the symposium. Visit the Annual Symposium web page for complete details! We look forward to seeing you in Washington, D.C., USA!

Don't miss out! You can still register online or by calling +1-847-375-6340.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Historic organ donation legislation for Wales officially passed
Wales Online
Historic legislation which will see Wales become the first U.K. nation to introduce a system of presumed consent has been officially passed. First Minister Carwyn Jones performed the official sealing of the Human Transplantation (Wales) Bill after the legislation received Royal Assent, completing the final stage in the legislative process.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ASSOCIATION NEWS


The 2014 call for abstracts will be open 24 September, 2013 through 15 January, 2014.




Like ITNS on Facebook! Visit the ITNS Facebook page for the latest ITNS and transplant news.


INDUSTRY NEWS


Will China's organ transplant reforms really work?
The Atlantic
The medical agency claims it's making policy changes, but recent scandals and a lack of transparency have the public questioning how successful they will be.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pioneering procedure allows woman, 51, to receive a new kidney from her father even though he has a different blood type
The Daily Mail
A woman has told how a pioneering treatment allowed her to have a life-saving kidney transplant. Tracey West, 51, who had chronic renal failure, has received a new kidney from her father, Michael, 71, despite the fact he has a different blood type. Until a few years ago, this would not have been possible as her body would have rejected the organ.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


1st heart/lung transplant in W. Michigan
WOOD-TV
Spectrum Health physicians recently performed the first combined heart and lung transplant in West Michigan. The procedure was performed Aug. 23 at the Spectrum Health Fred and Lena Meijer Heart Center in Grand Rapids. The transplant was the first such combined procedure done in Michigan since 1999 and the 15th in the state.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New kidney transplant safety test
Digital Journal
A simple test that can reveal whether a kidney transplant recipient is at imminent risk of organ rejection has been developed. The test checks urine levels of an immune protein. Essentially the test works by looking for increases in urine levels of an immune protein called CXCL9, according to Global Times. It has been found that the protein often shows up in patients a month before an episode of organ rejection, thereby acting as an "early warning."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Is there good news about the immunosuppressives drug bill in Congress?
Nephrology
Medication compliance is one of the most important ways to help insure the long term functioning of a transplanted kidney. To this end, the National Kidney Foundation and multiple other patient and professional transplant organizations are collaborating to enact legislation (S 323, HR 1428) to provide lifetime Medicare coverage of immunosuppressive drugs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Ohio family speaks out about botched transplant (The Associated Press via ABC News)
US: Who should be 1st in line to receive a transplant organ? (NPR)
The wave of the future: Noninvasive tests for kidney transplants (By Darla Ferrara)
Hand transplantation to become much more practical with Swiss research success (Science World Report)
'Breakthrough' method for diabetic transplants discovered (Medical News Today)

Don't be left behind. Click here to see what else you missed.


New system gives hospitals more time for lung transplants
Indiana Public Media
Indiana University Health Methodist Hospital is 1 of 7 centers in the country that is now using the XVIVO Lung Perfusion System. The system allows surgical teams to take somewhat marginal lungs, place them on the machine to study them and then perform interventions to improve the lung so it's usable for transplant.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Kidney transplants linked to invasive skin cancer
Medscape
Patients who receive organ transplants appear to be at increased risk for squamous cell carcinoma. In a brief report published in the Journal of Clinical Investigation, Dr. Laurence Verneuil, and colleagues from INSERM, University of Caen, France, give an explanation for this increased risk.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cancer drug shows promise preventing organ transplant rejection
RTT News
A previously existing cancer drug called Zebularine may help prevent the rejection of organ donor tissue according to a new study from researchers at Sweden's University of Rausing. For the study, the research team examined the drug by transplanting insulin producing cells into rats. They found that those rats who were also given Zebularine were far more likely to survive with the new tissue than those who were not:
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ITNS Insider

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Brie Ragland, Content Editor, 469.420.2639  
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the ITNS Insider was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Sept. 12, 2013
Sept. 5, 2013
Aug. 29, 2013
Aug. 22, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063